BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 122912)

  • 1. Streptozotocin therapy in 22 cancer patients.
    DuPriest RW; Huntington MC; Massey WH; Weiss AJ; Wilson WL; Fletcher WS
    Cancer; 1975 Feb; 35(2):358-67. PubMed ID: 122912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.
    Broder LE; Carter SK
    Ann Intern Med; 1973 Jul; 79(1):108-18. PubMed ID: 4352784
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase I evaluation of chlorozotocin (NSC-178248): weekly schedule.
    Moriconi WJ; Taylor S; Slavik M; Belt RJ; Haas CD; Hoogstraten B
    Invest New Drugs; 1985; 3(1):57-62. PubMed ID: 3157661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Streptozotocin and malignant insulinomas. Apropos of the case. Review of the literature].
    Beylot J; Veyret V; Vallat I; Longy M; Moretti G
    Sem Hop; 1976 Feb; 52(8):489-96. PubMed ID: 184544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptozotocin in the treatment of cancer: phase II study.
    Strolinsky DC; Sadoff L; Braunwald J; Bateman JR
    Cancer; 1972 Jul; 30(1):61-7. PubMed ID: 4261143
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
    Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
    Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998).
    Schein PS; O'Connell MJ; Blom J; Hubbard S; Magrath IT; Bergevin P; Wiernik PH; Ziegler JL; DeVita VT
    Cancer; 1974 Oct; 34(4):993-1000. PubMed ID: 4371075
    [No Abstract]   [Full Text] [Related]  

  • 8. Search for new cancer drugs: streptozotocin.
    Du Priest RW; Massey WH; Fletcher WS
    Am Surg; 1972 Sep; 38(9):514-20. PubMed ID: 4341764
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute renal failure and renal tubular squamous metaplasia following treatment with streptozotocin.
    Hall-Craggs M; Brenner DE; Vigorito RD; Sutherland JC
    Hum Pathol; 1982 Jun; 13(6):597-601. PubMed ID: 6281169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with adriamycin and streptozotocin. I. Clinical results in patients with advanced sarcoma.
    Chang P; Wiernik PH
    Clin Pharmacol Ther; 1976 Nov; 20(5):605-10. PubMed ID: 135666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of chlorozotocin.
    Gralla RJ; Tan CT; Young CW
    Cancer Treat Rep; 1979 Jan; 63(1):17-20. PubMed ID: 154363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide.
    Moertel CG; Douglas HO; Hanley J; Carbone PP
    Cancer; 1977 Aug; 40(2):605-8. PubMed ID: 142579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant metastatic pancreatic insulinoma with streptozotocin. Review of 21 cases described in detail in the literature and report of complete remission of a new case.
    Herbai G; Lundin A
    Acta Med Scand; 1976; 200(6):447-52. PubMed ID: 189576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Streptozotocin in hormone-active metastasizing islet-cell carcinoma].
    Spech HJ; Wernze H; Brunswig D
    Med Klin; 1973 Apr; 68(17):555-9. PubMed ID: 4350157
    [No Abstract]   [Full Text] [Related]  

  • 15. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Hanley JA; Johnson LA
    N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous streptozotocin infusion: a phase I study.
    Seibert K; Golub G; Smiledge P; Nystrom JS
    Cancer Treat Rep; 1979; 63(11-12):2035-7. PubMed ID: 160836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trials of maytansine, low-dose chlorozotocin, and high-dose chlorozotocin as single agents against advanced measurable adenocarcinoma of the pancreas. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1985 Apr; 69(4):417-20. PubMed ID: 2859924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
    Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
    Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptozotocin for malignant insulinomas and carcinoid tumor. Report of eight cases and review of the literature.
    Schein P; Kahn R; Gorden P; Wells S; Devita VT
    Arch Intern Med; 1973 Oct; 132(4):555-61. PubMed ID: 4355081
    [No Abstract]   [Full Text] [Related]  

  • 20. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.